Repairs or slows one important kind of damage.
What if each new treatment buys enough time to reach the next?
Aubrey de Grey has argued that the first person who could live for 1,000 years may already have been born. The important part is the chain of progress behind the claim.
You do not need one miracle that solves ageing forever.
Imagine that a treatment gives someone ten extra healthy years. During those ten years, research continues. A better treatment then gives more time. If progress eventually adds healthy life faster than ageing removes it, the person keeps reaching the next advance.
Science improves while the person remains healthier.
Several treatments begin to work together.
The future keeps moving away instead of closing in.
It changes how we look at early progress.
The first treatment does not have to produce centuries of life. It may only need to keep people healthier long enough for the next wave of medicine.
What to watch for
- Several ageing mechanisms treated together
- Reliable biological-age and healthspan measurements
- Human studies that restore function, not only a laboratory marker
- Safer repeat treatments
- Faster movement from discovery to human testing
A bold forecast is not a timetable.
The 1,000-year number is a possibility based on compounding progress, not a promised lifespan. RejuvAccess follows the smaller steps that would have to become real: repair, measurement, repeated treatment, wider access and continued improvement.